CRISPR-Generated Animal Models of Duchenne Muscular Dystrophy.

Kenji Rowel Q LimToshifumi Yokota


Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive neuromuscular disorder most commonly caused by mutations disrupting the reading frame of the dystrophin (DMD) gene. DMD codes for dystrophin, which is critical for maintaining the integrity of muscle cell membranes. Without dystrophin, muscle cells receive heightened mechanical stress, becoming more susceptible to damage. An active body of research continues to explore therapeutic treatments for DMD as well as to further our understanding of the disease. These efforts rely on having reliable animal models that accurately recapitulate disease presentation in humans. While current animal models of DMD have served this purpose well to some extent, each has its own limitations. To help overcome this, clustered regularly interspaced short palindromic repeat (CRISPR)-based technology has been extremely useful in creating novel animal models for DMD. This review focuses on animal models developed for DMD that have been created using CRISPR, their advantages and disadvantages as well as their applications in the DMD field.


Jan 1, 1991·Neuromuscular Disorders : NMD·A E Emery
Sep 20, 1991·Cell·J M Ervasti, K P Campbell
Apr 1, 1995·Journal of the Neurological Sciences·C Pastoret, A Sebille
Aug 1, 1993·The Journal of Cell Biology·J M Ervasti, K P Campbell
Aug 16, 2002·Nature·Simon G GregoryDavid R Bentley
Jun 17, 2003·Experimental Animals·Yoshiki ShimatsuShin'ichi Takeda
Apr 2, 2004·Nature·Alison Abbott
Jul 19, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Paul M L JanssenJill A Rafael-Fortney
Jul 11, 2006·Biochimica Et Biophysica Acta·James M Ervasti
Mar 16, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jeffrey S ChamberlainJohn A Faulkner
Mar 24, 2007·Science·Rodolphe BarrangouPhilippe Horvath
Jul 13, 2007·Genome Biology·Sean J HumphrayJane Rogers
Dec 18, 2007·The Journal of Biological Chemistry·Peter A C 't HoenJohan T den Dunnen
Aug 1, 2008·Archives of Disease in Childhood·A Y ManzurF Muntoni
Feb 3, 2009·Current Topics in Developmental Biology·Glen B Banks, Jeffrey S Chamberlain
Feb 17, 2009·Neuromuscular Disorders : NMD·Raffaella WillmannMarkus A Ruegg
Jan 30, 2010·International Journal of Toxicology·Peter SazaniStephen B Shrewsbury
Jan 6, 2012·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Joe N KornegayEric P Hoffman
Mar 28, 2012·Annals of Neurology·Jerry R MendellRobert B Weiss
Jun 29, 2012·Nature·Amy Maxmen
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Aug 14, 2013·Proceedings of the National Academy of Sciences of the United States of America·Zhonggang HouJames A Thomson
Jan 31, 2014·Nature·Samuel H SternbergJennifer A Doudna
Jun 12, 2014·Circulation Research·Qiurong DingKiran Musunuru
Jun 24, 2014·Scientific Reports·Masafumi InuiShuji Takada
Jul 10, 2014·Scientific Reports·Katsuyuki NakamuraMasugi Nishihara
Aug 8, 2014·Biology of Reproduction·Kristin M WhitworthRandall S Prather
Mar 6, 2015·Disease Models & Mechanisms·Joe W McGreevyDongsheng Duan
Apr 11, 2015·Human Molecular Genetics·Yongchang ChenXiao-Jiang Li
May 21, 2015·ILAR Journal·Joshua T SelsbyKatrin Hollinger
May 23, 2015·Molecular Cell·Samuel H Sternberg, Jennifer A Doudna
Jun 11, 2015·Genome Medicine·Haiwei MouWen Xue
Nov 19, 2015·The Plant Journal : for Cell and Molecular Biology·Jeannette SteinertHolger Puchta

❮ Previous
Next ❯


Sep 20, 2020·Journal of Personalized Medicine·Rika Maruyama, Toshifumi Yokota
Feb 12, 2021·Genes·Virginia Arechavala-Gomeza, Lidia Gonzalez-Quereda
Jun 22, 2021·Frontiers in Pharmacology·Leonela LuceFlorencia Giliberto
Jul 17, 2021·Cell & Bioscience·Xiaodong ZouXiaochun Tang
Jul 14, 2021·Cardiovascular Research·Francesco CanonicoDomenico D'Amario
Aug 20, 2021·Transgenic Research·M I ZaynitdinovaS A Smirnikhina

❮ Previous
Next ❯

Methods Mentioned

targeted mutations

Software Mentioned


Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Related Papers

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
Tongyu Li, Ping Liang
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Sonia Messina, Gian Luca Vita
© 2021 Meta ULC. All rights reserved